Immunovant, Inc. (IMVT) Q1 2027 Earnings Call Transcript

Roivant said its first quarter was relatively quiet operationally but positioned the company for a m

IMVT posts a wider quarterly loss as R&D spending rises, but its cash runway supports IMVT-1402 thro

All IMVT-1402 clinical development timelines remain on track, including ongoing studies in Graves' d

I initiate coverage of Immunovant with a BUY rating and a $50 price target, driven by optimism aroun

NEW YORK, July 20, 2026 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is i

Immunovant (IMVT) reported earnings 30 days ago. What's next for the stock?

IMVT shares climb as IMVT-1402 posts encouraging data, advances across autoimmune diseases and benef

Wall Street analysts changed outlook on top names. Guggenheim raised price target for IMVT, Piper Sa

Immunovant's underlying bull case has now moved away from batoclimab and toward IMVT-1402. This newe

Roivant (ROIV) remains a Buy as its unique 'vant' structure rapidly advances and monetizes blockbust

Immunovant Inc (NASDAQ:IMVT) on Wednesday posted a wider fourth‑quarter loss than analysts expected.

Immunovant stock jumps 35% as strong early IMVT-1402 data in rheumatoid arthritis boosts confidence

Immunovant Inc (NASDAQ:IMVT) shares are trading higher on Wednesday even though the company posted a

US stocks rise with Dow gaining 1% on Wednesday. The Nasdaq and S&P 500 also saw gains. Lowe&#39

Roivant executives used the company's fourth-quarter and fiscal-year earnings call to highlight new

TAT Technologies Ltd (TATT) reported better-than-expected Q1 results, sending shares up 11.7%. Other

DURHAM, N.C., May 20, 2026 (GLOBE NEWSWIRE) -- Immunovant, Inc. (Nasdaq: IMVT), a clinical-stage imm

DURHAM, N.C., May 11, 2026 (GLOBE NEWSWIRE) -- Immunovant (Nasdaq: IMVT) today announced that it wil

Immunovant, Inc. (NASDAQ: IMVT - Get Free Report) CTO Jay Stout sold 2,754 shares of Immunovant stoc

Arcus Biosciences (NYSE: RCUS - Get Free Report) and Immunovant (NASDAQ: IMVT - Get Free Report) are

Immunovant slips 2.4% after batoclimab misses key phase III endpoints in thyroid eye disease trials,

Roivant Sciences and Priovant Therapeutics executives outlined an expansion of the brepocitinib deve

Dow futures down 400 points, Alto Neuroscience shares dip 13.6% after Phase 2 trial results, other s

GSAT: 24% | Globalstar shares are trading higher following reports suggesting that Amazon is in disc

Amazon may acquire Globalstar Inc., shares soared in pre-market trading. Other gainers include Turbo

U.S. stocks traded lower, with the Nasdaq Composite falling around 100 points on Thursday. Here are

Gainers

  During Monday's trading, 1214 companies set new 52-week lows.

  On Friday, 422 stocks made new 52-week lows.

  Companies Reporting Before The Bell • Immunovant (NASDAQ:IMVT) is expected to report earnings fo

  On Wednesday, 807 companies reached new 52-week lows.

  During Wednesday's trading, 435 companies set new 52-week lows.

  During Thursday, 849 stocks hit new 52-week lows.

  Wednesday's session saw 784 companies set new 52-week lows.

  On Friday, 431 companies hit new 52-week lows.

    On Monday, 671 companies achieved new lows for the year.

    Tuesday's session saw 109 companies set new 52-week lows.

    On Friday, 209 companies set new 52-week lows.

  This morning 180 companies set new 52-week highs.